CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Patient Navigation ProgramWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug159 Anakinra Wiki 0.38
drug2527 Tocilizumab Wiki 0.19

Correlated MeSH Terms (5)

Name (Synonyms) Correlation
D055501 Macrophage Activation Syndrome NIH 1.00
D014777 Virus Diseases NIH 0.12
D007239 Infection NIH 0.06
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Navigating New Motherhood 2: Patient Navigation to Improve Outcomes Among Low-income Women in the Postpartum Period

The primary aim of this study is to determine whether implementation of a postpartum patient navigation program improves health outcomes among low-income women. Patient navigation is a barrier focused, long-term patient-centered intervention that offers support for a defined set of health services. The intervention under investigation is a comprehensive postpartum patient navigator program. Women who are randomized to receive patient navigation will be compared to women who are randomized to receive usual care. Navigators will support women through one year postpartum. The NNM2 program will be grounded in understanding and addressing social determinants of health in order to promote self-efficacy, enhance access, and sustain long-term engagement. Participants will undergo surveys, interviews, and medical record review at 4-12 weeks and 11-13 months postpartum. The investigators will additionally conduct focus groups and surveys with clinical providers.

NCT03922334 Postpartum Health Breastfeeding Contraception Preventive Care / Anticipatory Guidance Retention in Care Behavioral: Patient Navigation Program

Primary Outcomes

Description: Number of women who achieve a composite measure of health status that includes retention in care, receipt of recommended counseling (anticipatory guidance), receipt of desired contraception, postpartum depression screening and care, breastfeeding initiation and maintenance, and receipt of preventive care. (Outcome is modified to include receipt telemedicine for health care for women who require postpartum care during the pandemic)

Measure: Postpartum health at 4-12 weeks after delivery

Time: 4-12 weeks postpartum

Secondary Outcomes

Description: Among women with gestational diabetes mellitus (GDM), number of women with completion of a 2-hour oral glucose tolerance test by 12 weeks postpartum

Measure: Postpartum diabetes screening

Time: 4-12 weeks and 1 year postpartum

Description: Among women with ASCVD-associated adverse pregnancy outcomes, number of women who undergo indicated clinical assessments for blood pressure, lipids, weight, nutrition, activity

Measure: Postpartum atherosclerotic cardiovascular disease screening

Time: 4-12 weeks and 1 year postpartum

Description: Difference between weight at delivery and 1) weight at early postpartum (4-12 weeks) and 2) weight at 1 year postpartum

Measure: Gestational weight retention

Time: 4-12 weeks and 1 year postpartum

Description: Total duration of exclusive or partial breastfeeding among women who desired breastfeeding

Measure: Breastfeeding

Time: 4-12 weeks and 1 year postpartum

Description: Number of women with appointment made and kept for primary care by 1 year postpartum

Measure: Postpartum transition to primary care

Time: 1 year postpartum

Description: Differences between self-efficacy, activation, and engagement between women who are randomized to navigation versus usual care, using the Department of Health and Human Services (DHHS) Patient-Reported Outcomes Measurement Information System.

Measure: Patient-reported outcomes - self-efficacy, activation, and engagement

Time: 4-12 weeks and 1 year postpartum

Description: Qualitative perspectives on experiences with the navigation program, based on interviews with women who received navigation

Measure: Experiences with navigation

Time: 3-6 months postpartum and 1 year postpartum

Description: Qualitative perspective of participants' experiences during the COVID-19 pandemic, utilizing a semi-structured interview guide developed by the research team, as it relates to their receipt of health care, experiences as a pregnant person and new parent, and the role of patient navigation in this time period

Measure: Pregnancy/postpartum experiences during the pandemic

Time: At any point during the COVID-19 pandemic, up to 3 months after the end of the pandemic

Other Outcomes

Description: Qualitative feedback on how NNM2 can meet the needs of the clinicians and optimize the transition to primary care, as assessed by feedback from obstetrician and primary care provider focus groups

Measure: Evaluate clinician perspectives on patient navigation

Time: Through completion of study, an average of 3 years

Description: Number of clinicians who believed NNM2 met their needs and improved patient care, as determined by surveys feedback

Measure: Evaluate clinician experiences with NNM2

Time: Through completion of study, an average of 5 years

No related HPO nodes (Using clinical trials)